Cargando…

Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study

BACKGROUND: Multiple studies have demonstrated that neoadjuvant chemotherapy (NACT) can prolong the overall survival of pancreatic ductal adenocarcinoma (PDAC) patients. However, most studies have focused on open surgery following NACT. AIM: To investigate the efficacy and safety of laparoscopic rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yong-Gang, Huang, Xiao-Bing, Li, Yu-Ming, Li, Jing, Peng, Xue-Hui, Huang, Wen, Tang, Yi-Chen, Zheng, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516639/ https://www.ncbi.nlm.nih.gov/pubmed/36187398 http://dx.doi.org/10.4251/wjgo.v14.i9.1785

Ejemplares similares

Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature
por: Lovecek, Martin, et al.
Publicado: (2017)

Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection
por: Zhang, Li-Peng, et al.
Publicado: (2020)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection
por: Zhang, Li-Peng, et al.
Publicado: (2021)

Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
por: Pande, Rupaly, et al.
Publicado: (2022)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability
por: Shi, Hao-Jun, et al.
Publicado: (2016)

Identification of multiple risk factors for colorectal cancer relapse after laparoscopic radical resection
por: Luo, Jun, et al.
Publicado: (2023)

Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading
por: Seo, Woorim, et al.
Publicado: (2020)

Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreatic ductal adenocarcinoma
por: Wang, Rui, et al.
Publicado: (2023)

Comparison of clinical efficacy and postoperative inflammatory response between laparoscopic and open radical resection of colorectal cancer
por: He, Long-Hai, et al.
Publicado: (2022)

Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
por: Zhu, Yue-Lu, et al.
Publicado: (2019)

Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
por: Lew, Daniel, et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Successful robotic radical resection of hepatic echinococcosis located in posterosuperior liver segments
por: Zhao, Zhi-Ming, et al.
Publicado: (2020)

Sequential therapy with combined trans-papillary endoscopic naso-pancreatic and endoscopic retrograde pancreatic drainage for pancreatic pseudocysts
por: He, Yong-Gang, et al.
Publicado: (2021)

Comparative analysis of robotic vs laparoscopic radical hysterectomy for cervical cancer
por: Chen, Li, et al.
Publicado: (2019)

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
por: Zhu, Lingyu, et al.
Publicado: (2023)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Comparison of short- and long-term outcomes of laparoscopic vs open resection for gastric gastrointestinal stromal tumors
por: Ye, Xin, et al.
Publicado: (2017)

Utilization of deep neuromuscular blockade combined with reduced abdominal pressure in laparoscopic radical gastrectomy for gastric cancer: An academic perspective
por: Zhang, Yi-Wei, et al.
Publicado: (2023)

Retrospective review of total neoadjuvant therapy
por: Babar, Laila, et al.
Publicado: (2019)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

Four-year experience with more than 1000 cases of total laparoscopic liver resection in a single center
por: Lan, Xiang, et al.
Publicado: (2022)

Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction
por: Ma, Fu-Hai, et al.
Publicado: (2019)

Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail
por: Li, Zheng, et al.
Publicado: (2023)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

Impact of resection margins on long-term survival after pancreaticoduodenectomy for pancreatic head carcinoma
por: Li, Cheng-Gang, et al.
Publicado: (2019)

Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma
por: Hartley, Christopher, et al.
Publicado: (2020)

Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
por: Cloyd, Jordan M, et al.
Publicado: (2020)

Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
por: Li, Yang, et al.
Publicado: (2020)

Long-term outcomes and failure patterns after laparoscopic intersphincteric resection in ultralow rectal cancers
por: Qiu, Wen-Long, et al.
Publicado: (2023)

Low preoperative skeletal muscle index increases the risk of mortality among resectable pancreatic cancer patients: A retrospective study
por: Cai, Zhi-Wei, et al.
Publicado: (2022)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Feasibility of laparoscopic isolated caudate lobe resection for rare hepatic mesenchymal neoplasms
por: Li, Yang, et al.
Publicado: (2019)

Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy
por: Cui, Hao, et al.
Publicado: (2022)

Laparoscopic radical ‘no-touch’ left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results
por: Abu Hilal, M., et al.
Publicado: (2015)

Laparoscopic resection vs laparoscopic radiofrequency ablation for the treatment of small hepatocellular carcinomas: A single-center analysis
por: Casaccia, Marco, et al.
Publicado: (2017)

Causes of epigastric pain and vomiting after laparoscopic-assisted radical right hemicolectomy - superior mesenteric artery syndrome
por: Xie, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gc2mm3lj8gc5bggjksqnh07gcu